Immunology : Impact Factor & More
eISSN: 1365-2567pISSN: 0019-2805
Share this on:
Key Metrics
CiteScore 
13.4
H-Index
149
Impact Factor
5 - 10
SJR
Q1Immunology
SNIP
1.65
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Immunology
Immunology Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1958 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Immunology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Immunology
R-5780, a SagA-engineered Lactococcus lactis, is a safe oral synthetic-biology microbial therapy that potentiates PD-1 blockade.
- 30 Jun 2026
- Cancer immunology, immunotherapy : CII
Downregulation of ANKRD22 promotes ovarian cancer cell proliferation by enhancing the immunosuppressive capacity of M-MDSCs.
- 30 Jun 2026
- Cancer immunology, immunotherapy : CII
The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
CD68+ tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patients.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC).
- 23 Jun 2026
- Cancer immunology, immunotherapy : CII
R-5780, a SagA-engineered Lactococcus lactis, is a safe oral synthetic-biology microbial therapy that potentiates PD-1 blockade.
- 30 Jun 2026
- Cancer immunology, immunotherapy : CII
Downregulation of ANKRD22 promotes ovarian cancer cell proliferation by enhancing the immunosuppressive capacity of M-MDSCs.
- 30 Jun 2026
- Cancer immunology, immunotherapy : CII
The microbiota-lymphocyte protective axis (MLPA): a novel paradigm for overcoming radiation-induced lymphopenia (RIL) and potentiating the efficacy of tumor immuno-combination therapy.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
CD68+ tumor-associated macrophages exhibit prognostic value in surgically resected small cell lung cancer: a retrospective cohort study of 614 patients.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study.
- 29 Jun 2026
- Cancer immunology, immunotherapy : CII
Phase II study of 1st-line durvalumab and platinum-etoposide in advanced large-cell neuroendocrine lung carcinoma (aLCNEC).
- 23 Jun 2026
- Cancer immunology, immunotherapy : CII
FAQs on Immunology
How long has Immunology been actively publishing? 
What is the publishing frequency of Immunology?
How many articles did Immunology publish last year?
What is the eISSN & pISSN for Immunology?
What is Citescore for Immunology?
What is the H Index for Immunology ?
What is SNIP score for Immunology?
What is the SJR for Immunology?
Who is the publisher of Immunology?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations